StockNow
Calendar
Log in
U.S. Markets

US judge lets Eli Lilly (LLY) continue weight-loss drug ads, ruling against Novo Nordisk (NOVOB DC)

StockNow breaking-news AI analysis

The headline reports that Eli Lilly may continue weight-loss drug ads after a ruling against Novo Nordisk, but provides no details about the decision.

2 stocks
LLYEli Lilly & Co.$1,282.00Current priceNVONovo-Nordisk A/S$39.09Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Other

US Midterms (8 days out): Democrats’ early-vote lead narrows in 7 states; Texas and Nebraska flip to Republicans

Geopolitics

Iran, Pakistan, Turkey, and Saudi Arabia agreed to continue talks, IRIB reports

Geopolitics

Iranian Deputy Security Chief Bagheri Kani says Iran is open to a shorter US proposal timeline if conditions are met, state TV reports